Literature DB >> 16055013

First clinical data on RNAi.

Jo Whelan.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16055013     DOI： 10.1016/S1359-6446(05)03547-6

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  14 in total

Review 1.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

2.  HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.

Authors:  Behzad Mansoori; Ali Mohammadi; Solmaz Shirjang; Behzad Baradaran
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

3.  Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468).

Authors:  Behzad Mansoori; Ali Mohammadi; Samira Goldar; Dariush Shanehbandi; Leila Mohammadnejad; Elham Baghbani; Tohid Kazemi; Saeed Kachalaki; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2016-06-30

4.  Age-related macular degeneration: experimental and emerging treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.

Authors:  Mohamad Alameh; Diogo Dejesus; Myriam Jean; Vincent Darras; Marc Thibault; Marc Lavertu; Michael D Buschmann; Abderrazzak Merzouki
Journal:  Int J Nanomedicine       Date:  2012-03-13

6.  RNA interference: Perspectives and caveats.

Authors:  Jens Kurreck
Journal:  J RNAi Gene Silencing       Date:  2005-10-07

7.  Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

Authors:  Sterghios Athanasios Moschos; Simon Wyn Jones; Mark Michael Perry; Andrew Evan Williams; Jonas Sten Erjefalt; John James Turner; Peter John Barnes; Brian Stephen Sproat; Michael John Gait; Mark Andrew Lindsay
Journal:  Bioconjug Chem       Date:  2007-08-21       Impact factor: 4.774

Review 8.  RNA and disease.

Authors:  Thomas A Cooper; Lili Wan; Gideon Dreyfuss
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 9.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

Review 10.  Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

Authors:  Evelina Miele; Gian Paolo Spinelli; Ermanno Miele; Enzo Di Fabrizio; Elisabetta Ferretti; Silverio Tomao; Alberto Gulino
Journal:  Int J Nanomedicine       Date:  2012-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.